Improved glucose control associated with i.v. chromium administration in two patients receiving enteral nutrition

American Journal of Health-System Pharmacy

Volumn 67, Issue 7, 2010, Pages 535-541

  Phung, Olivia J ^a   Quercia, Robert A ^b   Keating, Kevin ^c   Baker, William L ^a   Bell, Jennifer L ^d   White, C Michael ^a,e   Coleman, Craig I ^a,e  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Department of Pharmacy Services ^*  (United States)

^c HH   (United States)

^d Food and Nutrition Services   (United States)

^e UC   (United States)

Author keywords

Chromic chloride; Diabetes mellitus; Dietary supplements; Dosage; Insulin; Insulins; Mechanism of action; Nutrition

Indexed keywords

CEFEPIME; CHROMIUM CHLORIDE; GLUCOSE; HALOPERIDOL; HYDROMORPHONE; INSULIN; INSULIN GLARGINE; LORAZEPAM; METHYLPREDNISOLONE SODIUM SUCCINATE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DELIRIUM TREMENS; DIABETIC PATIENT; DRUG EFFICACY; DRUG RESPONSE; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HEPATITIS C; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMONIA; PRIORITY JOURNAL; SUPPLEMENTATION;

EID: 77950605388     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090109     Document Type: Article

References (30)

1. Schwarz K, Mertz W. Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys. 1959; 85:292-295.
2. Jeejeebhoy KN, Chu RC, Marliss EB et al. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977; 30:531-538.
3. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000; 33:503-510.
4. Albarracin C, Fuqua B, Geohas J et al. Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial. J Cardiometab Syndr. 2007; 2:91-97.
5. Racek J, Trefil L, Rajdl D et al. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res. 2006; 109:215-230.
6. Pei D, Hsieh CH, Hung YJ et al. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metab Clin Exp. 2006; 55:923-927.
7. Martin J, Wang ZQ, Zhang XH et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006; 29:1826-32.
8. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002; 13:690-697.
9. Bahijiri SM, Mira SA, Mufti AM et al. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J. 2000; 21:831-837.
10. Anderson RA, Cheng N, Bryden NA et al. Elevated intakes of supplemental chromium improves glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997; 46:1786-1791.
11. Jovanovic-Peterson L, Gutierrez M, Peterson CM. Chromium supplementation for gestational diabetic women (GDM) improves glucose tolerance and decreases hyperinsulinemia. Diabetes. 1996; 45(2S):337a. Abstract.
12. Mossop RT. Effects of chromium III on fasting blood glucose, cholesterol, and cholesterol HDL levels in diabetics. Cent Afr J Med. 1983; 29:80-82.
13. Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 1980; 29:919-925.
14. Kleefstra N, Houweling ST, Jansman FG et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese western population. Diabetes Care. 2006; 29:521-525.
15. Guntin JE, Cheung NW, Hitchman R et al. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile. Diabetes Care. 2005; 28:712-713.
16. Althius MD, Jordan NE, Ludington EA et al. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002; 76:148-155.
17. Anderson RA, Roussel AM, Zouari N et al. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001; 20:212-218.
18. Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci. 2000; 55:M260-3.
19. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994; 17:1449-1452.
20. Thomas VL, Gropper SS. Effect of chromium and nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Elem Res. 1996; 55:297-305.
21. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism. 1992; 41:768-771.
22. Uusitupa MI, Mykkänen L, Siitonen O et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992; 68:209-216.
23. Uusitupa MI, Kumpulainen JT, Voutilainen E et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983; 38:404-410.
24. Rabinowitz MB, Gonick HC, Levin SR et al. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983; 6:319-327.
25. ConvertUnits.com. Chemical element: chromium (Cr). www.convertunits.com/ element/Chromium (accessed 2009 Apr 16).
26. Montori VM, Bistrian BR, MacMahon MM. Hyperglycemia in acutely ill patients. JAMA. 2002; 288:2167-2169.
27. Brown RO, Forloined-Lynn S, Cross RE et al. Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 1986; 31:661-664.
28. Via M, Scurlock C, Raikhelkar J et al. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Tract. 2008; 23:325-328.
29. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245.
30. Van der Hoven B, Schoonderbeek J, Groeninx van Zoelen C. Trace minerals in critically ill patients: forgotten cause of delayed recovery? Crit Care. 2004; 8(suppl):P264. Abstract.